Neuronetics (STIM) Consolidated Net Income (2017 - 2026)
Neuronetics' (STIM) quarterly Consolidated Net Income came in at -$11.3 million in Q1 2026, up 13.96% year-on-year from -$9.9 million in Q1 2025, and down 70.13% on a QoQ basis from -$6.6 million in Q4 2025.
Neuronetics (STIM) Consolidated Net Income (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Consolidated Net Income data on file, last reported at -$11.3 million in Q1 2026.
- On a quarterly basis, Consolidated Net Income rose 13.96% year-over-year to -$11.3 million in Q1 2026; TTM through Mar 2026 was -$48.2 million, a 4.93% decrease from a year earlier, with the FY2025 full-year figure at -$39.9 million, up 76.36% from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$11.3 million, down from -$6.6 million in the prior quarter.
- Over the last five years, Consolidated Net Income for STIM reached as high as -$6.1 million in Q4 2023 and fell as low as -$18.2 million in Q2 2025.
- Historically, Consolidated Net Income has averaged -$10.8 million across 5 years, with a median of -$10.1 million in 2024.
- Across the five-year window, Consolidated Net Income surged 56.22% in 2022 and tumbled 116.98% in 2024, its largest moves.
- Year by year, Consolidated Net Income stood at -$9.5 million in 2022, then jumped by 35.67% to -$6.1 million in 2023, then sank by 116.98% to -$13.2 million in 2024, then surged by 49.97% to -$6.6 million in 2025, then plunged by 70.13% to -$11.3 million in 2026.
- Per Business Quant data, the three most recent Consolidated Net Income figures were -$11.3 million in Q1 2026, -$6.6 million in Q4 2025, and -$12.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Neuronetics | 121.08 Mn | 115.08 Mn | 16.15 Mn | -11.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.26 Mn |
| Dec 31, 2025 | -6.62 Mn |
| Sep 30, 2025 | -12.10 Mn |
| Jun 30, 2025 | -18.19 Mn |
| Mar 31, 2025 | -13.09 Mn |
| Dec 31, 2024 | -13.23 Mn |
| Sep 30, 2024 | -9.45 Mn |
| Jun 30, 2024 | -10.14 Mn |
| Mar 31, 2024 | -8.69 Mn |
| Dec 31, 2023 | -6.10 Mn |
| Sep 30, 2023 | -10.06 Mn |
| Jun 30, 2023 | -8.35 Mn |
| Mar 31, 2023 | -11.16 Mn |
| Dec 31, 2022 | -9.48 Mn |
| Sep 30, 2022 | -8.71 Mn |
| Jun 30, 2022 | -11.09 Mn |
| Mar 31, 2022 | -15.27 Mn |
| Dec 31, 2021 | -7.26 Mn |
| Sep 30, 2021 | -12.79 Mn |
| Jun 30, 2021 | -25.33 Mn |